Gallium-68: all 52 studies that test it

Page 1 of 1. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.

• Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])RecruitingNCT07831824Phase 2/3
• Diagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm, Single-Center StudyNot yet recruitingNCT07830212Phase 2
• Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With CancerNot yet recruitingNCT07781852Early Phase 1
• Clinical Evaluation of [68Ga]Ga-ELI411 PET Imaging in Adult Patients With Solid TumorsEnrolling by invitationNCT07741006Early Phase 1
• Clinical Evaluation of [68Ga]Ga-FFD PET Imaging in Healthy Volunteers and Patients With Solid TumorsNot yet recruitingNCT07708103Early Phase 1
• A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic CancerRecruitingNCT07707531Early Phase 1
• [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsRecruitingNCT07702292Phase 2
• A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate CancerRecruitingNCT07689656Phase 1/2
• First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic CancerRecruitingNCT07608848Early Phase 1
• A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate CancerRecruitingNCT07600554Phase 1
• Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.RecruitingNCT07577206Early Phase 1
• Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell CarcinomaRecruitingNCT07301827Not applicable
• Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary TumorsEnrolling by invitationNCT07254104Early Phase 1
• Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)RecruitingNCT07219238Phase 2/3
• A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung CancersRecruitingNCT07117214Phase 1
• [Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck CancersNot yet recruitingNCT07026981Early Phase 1
• Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung CancerRecruitingNCT07026110Not applicable
• [68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)RecruitingNCT07020806Phase 1
• CD70-targeted immunoPET Imaging of Malignant CancersRecruitingNCT06852638Phase 2
• Trop2-targeted immunoPET Imaging of Solid TumorsRecruitingNCT06851663Phase 2/3
• Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted TherapyRecruitingNCT06828588Early Phase 1
• [68Ga]Ga-FAPI-46 in Staging of Head and Neck CarcinomasRecruitingNCT06794372Phase 2
• The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural MesotheliomaRecruitingNCT06790082Phase 2
• Target-specific immunoPET Imaging of Digestive System CarcinomaRecruitingNCT06715839Not applicable
• Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular ImagingRecruitingNCT06715020Not applicable
• Phase IIT Trial of SNA014Not yet recruitingNCT06646783Early Phase 1
• A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.RecruitingNCT06562361Early Phase 1
• Evaluation of [68Ga]Ga-PentixaFor PET Imaging for the Identification of Unilateral Adrenal Secretion of ALdosterON in Patients With Primary AldosteronismNot yet recruitingNCT06478875Phase 2
• Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and MetastasisRecruitingNCT06462508Early Phase 1
• [68Ga]Ga-P15-041 PET/CT in Variety of Bone TumorsRecruitingNCT06455722Early Phase 1
• Study on B7-H3 Targeted Affibody Radioligand Probes for PET Imaging of Solid TumorsRecruitingNCT06454955Early Phase 1
• [68Ga]Ga-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer PatientsRecruitingNCT06419361Early Phase 1
• Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic CarcinomasRecruitingNCT06389123Phase 1
• Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6RecruitingNCT06228482Phase 1
• Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and MetastasisRecruitingNCT05955677Early Phase 1
• Study of Novel PET Tracer Gallium [68Ga]/ Fluorine [18F] -FAPI-04 in the Diagnosis of Cardiovascular DiseasesRecruitingNCT05867589Not applicable
• A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin CancerRecruitingNCT05562791Phase 1
• A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in JapanCompletedNCT06240741Phase 3Results posted
• [68Ga]DOTATATE-PET/MRI in Hepatocellular CarcinomaCompletedNCT03648073Phase 1/2Results posted
• 68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)CompletedNCT03490032Phase 1/2Results posted
• A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive CancerCompletedNCT06840548Phase 1
• A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate CancerCompletedNCT06840535Phase 1
• First Human Trial of Targeting MDM2/MDMX PET ImagingCompletedNCT06443762Early Phase 1
• PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid TumorsCompletedNCT06383598Not applicable
• Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast CancerCompletedNCT05889728Phase 2
• A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid TumorsCompletedNCT05784597Phase 1
• [68Ga]Ga-PentixaFor PET/CT in Acute Myocardial InflammationTerminatedNCT05499637Phase 2
• [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma PatientsStatus unknownNCT05034783Early Phase 1
• First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic CancerActive, not recruitingNCT04665947Early Phase 1
• A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus PatientsCompletedNCT03350191Phase 1
• [68 Ga]-DOTANOC PET/CT in GEP-NETsCompletedNCT02608203Phase 2/3
• PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy VolunteersCompletedNCT01205321Phase 1

← Gallium-68 overview